298 related articles for article (PubMed ID: 25007066)
1. Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapies.
Amado NG; Predes D; Moreno MM; Carvalho IO; Mendes FA; Abreu JG
Int J Mol Sci; 2014 Jul; 15(7):12094-106. PubMed ID: 25007066
[TBL] [Abstract][Full Text] [Related]
2. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.
Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A
Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
4. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
[TBL] [Abstract][Full Text] [Related]
5. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
[TBL] [Abstract][Full Text] [Related]
6. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Mashima T; Taneda Y; Jang MK; Mizutani A; Muramatsu Y; Yoshida H; Sato A; Tanaka N; Sugimoto Y; Seimiya H
Oncotarget; 2017 Jul; 8(29):47902-47915. PubMed ID: 28615517
[TBL] [Abstract][Full Text] [Related]
7. Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation.
Ali I; Medegan B; Braun DP
Int J Mol Sci; 2016 Apr; 17(4):495. PubMed ID: 27049382
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Potential of Targeting Wnt/β-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress.
Bahrami A; Amerizadeh F; ShahidSales S; Khazaei M; Ghayour-Mobarhan M; Sadeghnia HR; Maftouh M; Hassanian SM; Avan A
J Cell Biochem; 2017 Aug; 118(8):1979-1983. PubMed ID: 28109136
[TBL] [Abstract][Full Text] [Related]
9. Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth.
Wang J; Mook RA; Ren XR; Zhang Q; Jing G; Lu M; Spasojevic I; Lyerly HK; Hsu D; Chen W
Bioorg Med Chem; 2018 Nov; 26(20):5435-5442. PubMed ID: 30274939
[TBL] [Abstract][Full Text] [Related]
10. Role of Wnt/
Yuan S; Tao F; Zhang X; Zhang Y; Sun X; Wu D
Biomed Res Int; 2020; 2020():9390878. PubMed ID: 32258160
[TBL] [Abstract][Full Text] [Related]
11. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
[TBL] [Abstract][Full Text] [Related]
13. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
[TBL] [Abstract][Full Text] [Related]
14. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancer.
Sabatino L; Pancione M; Votino C; Colangelo T; Lupo A; Novellino E; Lavecchia A; Colantuoni V
World J Gastroenterol; 2014 Jun; 20(23):7137-51. PubMed ID: 24966585
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Wnt/β-catenin signaling pathway by bioactive food components.
Tarapore RS; Siddiqui IA; Mukhtar H
Carcinogenesis; 2012 Mar; 33(3):483-91. PubMed ID: 22198211
[TBL] [Abstract][Full Text] [Related]
17. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
[TBL] [Abstract][Full Text] [Related]
19. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
Jiang X; Tan J; Li J; Kivimäe S; Yang X; Zhuang L; Lee PL; Chan MT; Stanton LW; Liu ET; Cheyette BN; Yu Q
Cancer Cell; 2008 Jun; 13(6):529-41. PubMed ID: 18538736
[TBL] [Abstract][Full Text] [Related]
20. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
Ye Y; Gu B; Wang Y; Shen S; Huang W
Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
[No Abstract] [Full Text] [Related]
[Next] [New Search]